Showing results (331-340 of 551) with videos related to
Sort By:
Pageof 56
Journal of Clinical Medicine|November 13, 2021
Age and Sex Specific Prevalence of Clinical and Screen-Detected Atrial Fibrillation in Hospitalized PatientsLaurent Roten, Eleni Goulouti, Anna Lam, et al.Journal of Personalized Medicine|September 23, 2022
Experiences of Migrant People Living with HIV in a Multidisciplinary HIV Care Setting with Rapid B/F/TAF Initiation and Cost-Covered Treatment: The 'ASAP' StudyAnish K Arora, Kim Engler, David Lessard, et al.European Urology|July 13, 2014
TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancerStefan Steurer, Pascale Sophia Mayer, Meike Adam, et al.Journal of Environmental Management|May 18, 2025
Towards transformative change for biodiversity: What can we learn from case studies in Germany?Vera Schreiner, Marion Mehring, Janina Kleemann, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|January 25, 2021
Overexpression of the TRIM24 E3 Ubiquitin Ligase is Linked to Genetic Instability and Predicts Unfavorable Prognosis in Prostate CancerDoris Höflmayer, Christoph Fraune, Claudia Hube-Magg, et al.Urologic Oncology|November 24, 2019
8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survivalTill Eichenauer, David C Bannenberg, Martina Kluth, et al.Scientific Reports|May 19, 2017
Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancerAsmus Heumann, Özge Kaya, Christoph Burdelski, et al.Oncotarget|November 24, 2016
Deletion of 8p is an independent prognostic parameter in prostate cancerMartina Kluth, Nina Nadine Amschler, Rami Galal, et al.BMC Cancer|January 7, 2018
High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancerAsmus Heumann, Nina Heinemann, Claudia Hube-Magg, et al.Scientific Reports|August 22, 2018
Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancerAsmus Heumann, Özge Kaya, Christoph Burdelski, et al.Pageof 56